| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420395 Disorders or diseases involving the cholinergic system of the central nervous system, pain, inflammatory diseases, diseases caused by smooth muscle contractions and as assistance in the cessation of chemical substance abuse. |
| 07/16/2002 | US6420394 Topically applied pharmaceutical formulation |
| 07/16/2002 | US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or |
| 07/16/2002 | US6420390 Heteroarylpiperidines and their use as antipsychotics |
| 07/16/2002 | US6420388 Osanetant in the treatment of depression and depressive disorders |
| 07/16/2002 | US6420386 Spinal traumatism, epilepsy, chronic neurodegenerative diseases such as alzheimer's disease, schizophrenia, lateral amyotrophic sclerosis or huntington's chorea. |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420376 Amido spiropiperidines promote the release of growth hormone |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/16/2002 | US6420351 Administering mixture of alanine, serine, methylglycine and cycloserine |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/16/2002 | US6419956 Odor-masking coating for a pharmaceutical preparation |
| 07/16/2002 | CA2236158C Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/16/2002 | CA2206172C New derivatives of 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/16/2002 | CA2205998C Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| 07/16/2002 | CA2165519C P substance antagonist used for the treatment of itching, ocular and/or palpebral algia and ocular and/or palpebral dysesthesia |
| 07/16/2002 | CA2119511C Benzimidazole compounds, their use and preparation |
| 07/16/2002 | CA2116956C Pharmaceutical process |
| 07/16/2002 | CA2105977C Thiocarbamate sulfoxide composition for deterring ethanol ingestion |
| 07/16/2002 | CA2063594C 5-(1-aminocyclohexyl)-2(1h)-pyridinone and related compounds |
| 07/16/2002 | CA2059704C [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives |
| 07/16/2002 | CA2050875C 3-(1h-indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments |
| 07/11/2002 | WO2002054066A2 Non-apoptotic forms of cell death and methods of modulation |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053736A1 Method of examining ability to control nerve cell plasticity |
| 07/11/2002 | WO2002053735A1 Trasncription activation complex and utilization thereof |
| 07/11/2002 | WO2002053729A1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/11/2002 | WO2002053594A2 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | WO2002053580A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | WO2002053577A2 Gabaa modulating neurosteroids |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053561A1 Excitatory amino acid receptor antagonists |
| 07/11/2002 | WO2002053559A1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053556A2 Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 07/11/2002 | WO2002053555A2 Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 07/11/2002 | WO2002053533A2 Kappa opioid receptor ligands |
| 07/11/2002 | WO2002053522A2 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053516A2 N(phenylsulphonyl)glycine derivatives and their therapeutic use |
| 07/11/2002 | WO2002053177A2 Agents and methods for treating pain |
| 07/11/2002 | WO2002053169A2 Use of dipeptylpeptidase iv and aminopeptidase-n inhibitors in the treatment of ischaemia-induced neuro-degeneration |
| 07/11/2002 | WO2002053159A1 Neurotrophic tacrolimus analogs |
| 07/11/2002 | WO2002053154A1 Pharmaceutical emulsion preparation |
| 07/11/2002 | WO2002053153A1 Medicines for treatment and prevention of neurogenic pain |
| 07/11/2002 | WO2002053152A1 Composition containing flavonoids for treatment brain disorders |
| 07/11/2002 | WO2002053151A1 Perfume compositions |
| 07/11/2002 | WO2002053140A2 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | WO2002053139A2 Excitatory amino acid receptor antagonist and 5-ht1f agonist combination: a method for the treatment of neurological disorders |
| 07/11/2002 | WO2002053133A1 Pharmaceutical composition containing citalopram |
| 07/11/2002 | WO2002053104A2 Use of catecholamine reuptake inhibitors to enhance memory |
| 07/11/2002 | WO2002053100A2 Pharmaceutical dosage form for oral administration of low molecular weight heparin |
| 07/11/2002 | WO2002052957A1 Creatine/citric acid compound, method for the production of the same and the use thereof |
| 07/11/2002 | WO2002038144A8 The use of tiagabine for treatment of diabetic neuropathy and migraine |
| 07/11/2002 | WO2002036605A3 Estrone-derivatives having cytoprotective activity |
| 07/11/2002 | WO2002034754A3 Benzoxazinone derivatives, their preparation and use |
| 07/11/2002 | WO2002030354A3 Uridine therapy for patients with elevated purine levels |
| 07/11/2002 | WO2002028480A3 Methods of therapy for b-cell malignancies |
| 07/11/2002 | WO2002024658A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002024657A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002018348A3 Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/11/2002 | WO2002017914A8 Fused pyrrolocarbazoles against inflammation |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002011666A3 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008221A3 Capsaicin receptor ligands |
| 07/11/2002 | WO2001096311A3 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 07/11/2002 | WO2001091783A3 Methods and compositions for producing a neurosalutary effect in a subject |
| 07/11/2002 | WO2001068067A3 Use of deramciclane for the treatment of anxiety and depression |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001043540A3 Methods for producing transgenic animals |
| 07/11/2002 | WO2001040187A3 Compound having effect of promoting neuron differentiation |
| 07/11/2002 | WO2001035939A3 Oleamide in epilepsy |
| 07/11/2002 | WO2001034639A3 β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 07/11/2002 | WO2001034225A3 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 07/11/2002 | WO2001034125A3 Therapeutic use and formulation of (-)-tramadol |
| 07/11/2002 | WO2001028540A3 Agent for treating cephalic pain |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001024785A3 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 07/11/2002 | WO2001021213A3 Inhibition of secretion from non-neuronal cells |
| 07/11/2002 | WO2001021178A3 Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | WO2001016120A9 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 07/11/2002 | WO2001010430A9 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 07/11/2002 | WO2001003680A3 Compounds for inhibiting diseases and preparing cells for transplantation |
| 07/11/2002 | WO2000075173A3 Peptide fragments of colostrinin |
| 07/11/2002 | WO2000075144A9 Peroxynitrite decomposition catalysts and methods of use thereof |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000072834A3 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 07/11/2002 | WO2000067016A9 Methods for the identification of compounds for the treatment of alzheimer's disease |
| 07/11/2002 | WO2000064911A9 Ligands for metabotropic glutamate receptors |